Literature DB >> 23355920

Hepatic sarcoidosis complicating treatment-naive viral hepatitis.

Aloysious Aravinthan1, William Gelson, Anita Limbu, Rebecca Brais, Paul Richardson.   

Abstract

Hepatic sarcoidosis is usually asymptomatic but rarely leads to adverse liver-related outcome. Co-existence of viral hepatitis and hepatic sarcoidosis is a rare, but recognised phenomenon. Obtaining a balance between immune suppression and anti-viral therapy may be problematic. Immunosuppression in the presence of viral hepatitis can lead to rapid deterioration of liver disease. Similarly, anti-viral therapy may exacerbate granulomatous hepatitis. Here we present two cases of viral hepatitis co-existing with sarcoidosis that illustrate successful management strategies. In one, hepatitis B replication was suppressed with oral anti-viral therapy before commencing prednisolone. In the second, remission of hepatic sarcoidosis was achieved with prednisolone, before treating hepatitis C and obtaining a sustained virological response with pegylated interferon and ribavirin therapy.

Entities:  

Keywords:  Anti-viral therapy; Chronic hepatitis B infection; Chronic hepatitis C infection; Hepatic sarcoidosis; Immune suppression

Year:  2012        PMID: 23355920      PMCID: PMC3554806          DOI: 10.4254/wjh.v4.i12.402

Source DB:  PubMed          Journal:  World J Hepatol


  23 in total

Review 1.  Reactivation of sarcoidosis during interferon therapy.

Authors:  Shilun D Li; Sherri Yong; Dasarathy Srinivas; David H Van Thiel
Journal:  J Gastroenterol       Date:  2002-01       Impact factor: 7.527

2.  Sarcoidosis, chronic hepatitis C and interferon-alpha: two cases.

Authors:  Sauro Luchi; Antonio Scasso
Journal:  Scand J Infect Dis       Date:  2003

Review 3.  Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: role of Lamivudine prophylaxis.

Authors:  Bertrand Coiffier
Journal:  Cancer Invest       Date:  2006 Aug-Sep       Impact factor: 2.176

4.  Cutaneous, pulmonary and hepatic sarcoidosis associated with autoimmune complications during interferon-alpha treatment for hepatitis C virus infection.

Authors:  B N Akay; P Ekmekci; H Sanli; G Celik; M Bozdayi
Journal:  J Eur Acad Dermatol Venereol       Date:  2006-04       Impact factor: 6.166

5.  Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine.

Authors:  R Pérez-Alvarez; R Pérez-López; J L S Lombraña; M Rodríguez; L Rodrigo
Journal:  J Viral Hepat       Date:  2002-01       Impact factor: 3.728

6.  Prevalence of hepatic granulomas in chronic hepatitis B.

Authors:  Veysel Tahan; Resat Ozaras; Nadir Lacevic; Ercan Ozden; Mucahit Yemisen; Osman Ozdogan; Ali Mert; Fehmi Tabak; Erol Avsar; Cigdem Ataizi Celikel; Gulsen Ozbay; Cem Kalayci; Hakan Senturk; Nurdan Tozun
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

Review 7.  Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases.

Authors:  Manuel Ramos-Casals; Juan Mañá; Norma Nardi; Pilar Brito-Zerón; Antoni Xaubet; José Maria Sánchez-Tapias; Ricard Cervera; Josep Font
Journal:  Medicine (Baltimore)       Date:  2005-03       Impact factor: 1.889

8.  The prevalence of hepatic granulomas in chronic hepatitis C.

Authors:  Resat Ozaras; Veysel Tahan; Ali Mert; Suleyman Uraz; Mustafa Kanat; Fehmi Tabak; Erol Avsar; Gulsen Ozbay; Cigdem Ataizi Celikel; Nurdan Tozun; Hakan Senturk
Journal:  J Clin Gastroenterol       Date:  2004 May-Jun       Impact factor: 3.062

Review 9.  Clinical manifestations of sarcoid liver disease.

Authors:  Miry Blich; Yeouda Edoute
Journal:  J Gastroenterol Hepatol       Date:  2004-07       Impact factor: 4.029

10.  Diagnosis and treatment of hepatic sarcoidosis.

Authors:  Uma S Ayyala; Maria L Padilla
Journal:  Curr Treat Options Gastroenterol       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.